LLY News

Lilly to participate in Citi's 2025 Global Healthcare Conference

The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet

Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight

Lilly plans to build a new €2.6 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide

Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance

Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States

Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability